Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Excalibur Fund Managers
AddedFeb 19, 2024
UpdatedJun 28, 2026
Excalibur Fund Managers

Excalibur Fund Managers

Operating

Excalibur Fund Managers: A proactive venture capital firm investing in medical and life sciences sectors globally since 1996.

Location
London, Greater London, GB
Founded
1996
Firm
Compare
Portfolio
Employees
Website

Excalibur Fund Managers is a venture capital firm specializing in early, mid, and late-stage investments. The firm focuses on the medical sciences, biotechnology, and life sciences sectors, targeting companies that bring human medicines or medical devices to market. Excalibur prefers to invest in companies based in the United Kingdom, United States, and Europe, actively participating in their growth by taking board seats.

Notable portfolio companies include Cyclacel, which has raised $26.3 million. Excalibur's key partners are seasoned professionals with extensive experience in the medical and life sciences sectors. The firm's investment philosophy emphasizes active involvement and strategic guidance to help portfolio companies achieve significant milestones. Excalibur offers unique value-add services such as strategic advisory and operational support to ensure the success of its investments.

Excalibur Fund Managers - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count1
Total Portfolio Exits0

Top Investment Stages

Seed1 (50.0%)
Series D1 (50.0%)

Stage Mix

Seed 50%Series D 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Bio Green Med Solution logo

Bio Green Med Solution

Excalibur Fund Managers - Similar Investment Firms

Excel Venture Management logo

Excel Venture Management

excelvm.com

Advent Life Sciences logo

Advent Life Sciences

adventls.com

Luminous Ventures logo

Luminous Ventures

luminous.vc

Expeditions Fund logo

Expeditions Fund

Lux Capital logo

Lux Capital

luxcapital.com

Axil Capital logo

Axil Capital

axilcapital.com

Sitka Partners logo

Sitka Partners

sitkapartners.com

Albion Capital Group logo

Albion Capital Group

albion.capital

eLab Ventures logo

eLab Ventures

elabvc.com

Avalon Ventures logo

Avalon Ventures

Alta Berkeley Venture Partners logo

Alta Berkeley Venture Partners

Epidarex Capital logo

Epidarex Capital

epidarex.com

Excell Partners logo

Excell Partners

excellny.com

GBP Capital logo

GBP Capital

Global Life Science Ventures logo

Global Life Science Ventures

Excalibur Fund Managers - Classification

Also Known As
  • Excalibur Fund Managers Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end